Literature DB >> 18310543

Investigation of FDG-PET/CT imaging to guide biopsies in the detection of histological transformation of indolent lymphoma.

Caroline Bodet-Milin, Françoise Kraeber-Bodéré, Philippe Moreau, Loïc Campion, Benoît Dupas, Steven Le Gouill.   

Abstract

Positron emission tomography using 18F-fluorodeoxyglucose (FDG-PET) has been successfully evaluated in the management of non-Hodgkin's lymphoma (NHL).1-3 Histological transformation (HT) of indolent lymphoma is a dramatic event that occurs in 5-10% of the patients and carries a dismal prognosis.4,5 Previous studies prove that indolent lymphoma entities show a lower FDG uptake when compared with aggressive lymphomas.6-8 We therefore postulated that FDG-PET/CT identifies aggressive transformation sites and can guide biopsies.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18310543     DOI： 10.3324/haematol.12013

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


  33 in total

Review 1.  Impact of (18)F-FDG PET/CT on the staging and management of follicular lymphoma.

Authors:  U Metser; D Hussey; G Murphy
Journal:  Br J Radiol       Date:  2014-07-25       Impact factor: 3.039

Review 2.  FDG PET-CT in follicular lymphoma: a case-based evidence review.

Authors:  Stephen D Smith; Mary Redman; Kieron Dunleavy
Journal:  Blood       Date:  2014-12-19       Impact factor: 22.113

Review 3.  FDG PET/CT imaging as a biomarker in lymphoma.

Authors:  Michel Meignan; Emmanuel Itti; Andrea Gallamini; Anas Younes
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-01-09       Impact factor: 9.236

Review 4.  Imaging in Lymphoma: The Key Role of Fluorodeoxyglucose-Positron Emission Tomography.

Authors:  Michel Meignan; Martin Hutchings; Lawrence H Schwartz
Journal:  Oncologist       Date:  2015-07-14

5.  Reply to: "All that glitters is not gold - new reconstruction methods using Deauville criteria for patient reporting".

Authors:  Charline Lasnon; Blandine Enilorac; Nicolas Aide
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-02-23       Impact factor: 9.236

6.  Positron-emission tomography-based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma.

Authors:  Connie L Batlevi; Fushen Sha; Anna Alperovich; Ai Ni; Katy Smith; Zhitao Ying; John F Gerecitano; Paul A Hamlin; Steve M Horwitz; Erel Joffe; Anita Kumar; Matthew J Matasar; Alison J Moskowitz; Craig H Moskowitz; Ariela Noy; Colette Owens; Lia M Palomba; David Straus; Gottfried von Keudell; Andrew D Zelenetz; Venkatraman E Seshan; Stefano Luminari; Luigi Marcheselli; Massimo Federico; Anas Younes
Journal:  Eur J Cancer       Date:  2020-01-08       Impact factor: 9.162

7.  Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group.

Authors:  Caroline Bodet-Milin; Cyrille Touzeau; Christophe Leux; Mehmet Sahin; Anne Moreau; Hervé Maisonneuve; Nadine Morineau; Henry Jardel; Philippe Moreau; Céline Gallazini-Crépin; Pascal Gries; Rémy Gressin; Jean-Luc Harousseau; Mohamad Mohty; Philippe Moreau; Françoise Kraeber-Bodere; Steven Le Gouill
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-04-29       Impact factor: 9.236

8.  Uptake of [18F]fluorodeoxyglucose in initial positron-emission tomography predicts survival in MALT lymphoma.

Authors:  Shunan Qi; May Y Huang; Yong Yang; Heiko Schöder; Sewit Teckie; Ariela Noy; Karen Chau; Joachim Yahalom
Journal:  Blood Adv       Date:  2018-03-27

9.  Metabolic tumour volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients.

Authors:  Michel Meignan; Myriam Sasanelli; René Olivier Casasnovas; Stefano Luminari; Federica Fioroni; Chiara Coriani; Helene Masset; Emmanuel Itti; Paolo G Gobbi; Francesco Merli; Annibale Versari
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-26       Impact factor: 9.236

10.  Comparison of CT, PET, and PET/CT for staging of patients with indolent non-Hodgkin's lymphoma.

Authors:  Barbara J Fueger; Kristen Yeom; Johannes Czernin; James W Sayre; Michael E Phelps; Martin S Allen-Auerbach
Journal:  Mol Imaging Biol       Date:  2009-03-27       Impact factor: 3.488
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.